Differin Acne Clearing Body Wash

Description

DIFFERIN® CLEANSE ACNE - CLEARING BODY WASH is an acne treatment formulated with 2% Salicylic Acid, designed to effectively unclog pores. This body wash also incorporates Blue Tansy Extract, which provides soothing properties. It is intended for application on the chest, back, and shoulders, offering dryness relief for up to 24 hours. The product is available in a 10 FL OZ (295 mL) container.

Uses and Indications

This drug is indicated for the management of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The medication should be applied to dampened skin, ensuring that it is gently massaged into the area of application. Following the massage, the product must be rinsed thoroughly with warm water to remove any residue. After rinsing, the skin should be patted dry with a clean towel.

In the event that bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to minimize these side effects. Healthcare professionals should monitor the patient's response to treatment and adjust the application regimen as necessary to ensure optimal comfort and efficacy.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Discontinue use and consult a healthcare professional if severe irritation develops. Concurrent use with other topical acne medications may increase the risk of skin irritation and dryness; therefore, it is recommended to use only one topical acne medication at a time to minimize this risk.

Warnings and Precautions

For external use only. This product is not intended for ingestion. In the event of accidental swallowing, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately.

Healthcare professionals should advise patients to discontinue use and consult a physician if severe irritation occurs. Monitoring for signs of irritation is recommended to ensure patient safety and appropriate management of any adverse reactions.

Side Effects

Patients should be aware that the product is intended for external use only. In the event that irritation becomes severe, it is advised to stop use and consult a healthcare professional.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Differin Acne Clearing Body Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of DIFFERIN ACNE CLEARING BODY WASH, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when considering this product for geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects, given the lack of targeted data in this population.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid during pregnancy is generally not recommended due to potential risks to the fetus, including the possibility of teratogenic effects. Pregnant women are advised to consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or its effects during lactation. Additionally, there is no available data on the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the absence of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, specific antidotes or treatments may be indicated depending on the substance involved in the overdose. It is crucial for healthcare professionals to consult relevant clinical guidelines and toxicology resources to determine the most effective management strategies tailored to the individual case.

In summary, while no specific overdosage information is provided, vigilance and prompt intervention are paramount in managing potential overdose situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for healthcare providers to emphasize the seriousness of this action and the need for prompt intervention.

Patients should also be instructed to discontinue use and consult a doctor if they experience severe irritation. This guidance is crucial to prevent potential complications and ensure patient safety.

Additionally, patients should be made aware that the likelihood of skin irritation and dryness may increase if they are using another topical acne medication concurrently. Healthcare providers should recommend that patients use only one topical acne medication at a time to minimize the risk of irritation and enhance treatment efficacy.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the use of multiple topical acne medications concurrently may increase the likelihood of skin irritation and dryness. If patients experience severe irritation, they should discontinue use and consult a healthcare professional.

It is crucial to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Differin Acne Clearing Body Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)